174 related articles for article (PubMed ID: 33021505)
1. The N-terminal length and side-chain composition of CXCL13 affect crystallization, structure and functional activity.
Rosenberg EM; Herrington J; Rajasekaran D; Murphy JW; Pantouris G; Lolis EJ
Acta Crystallogr D Struct Biol; 2020 Oct; 76(Pt 10):1033-1049. PubMed ID: 33021505
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
[TBL] [Abstract][Full Text] [Related]
3. CXCL13/CXCR5 signaling axis in cancer.
Hussain M; Adah D; Tariq M; Lu Y; Zhang J; Liu J
Life Sci; 2019 Jun; 227():175-186. PubMed ID: 31026453
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.
Cagigi A; Mowafi F; Phuong Dang LV; Tenner-Racz K; Atlas A; Grutzmeier S; Racz P; Chiodi F; Nilsson A
Blood; 2008 Dec; 112(12):4401-10. PubMed ID: 18780835
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of CXCL13 and heparan sulfate binding show that GAG binding site and cellular signalling rely on distinct domains.
Monneau YR; Luo L; Sankaranarayanan NV; Nagarajan B; Vivès RR; Baleux F; Desai UR; Arenzana-Seidedos F; Lortat-Jacob H
Open Biol; 2017 Oct; 7(10):. PubMed ID: 29070611
[TBL] [Abstract][Full Text] [Related]
6. The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF.
Harrer C; Otto F; Pilz G; Haschke-Becher E; Trinka E; Hitzl W; Wipfler P; Harrer A
Fluids Barriers CNS; 2021 Aug; 18(1):40. PubMed ID: 34446066
[TBL] [Abstract][Full Text] [Related]
7. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
[TBL] [Abstract][Full Text] [Related]
8. Increased CXCL13 and CXCR5 in Anterior Cingulate Cortex Contributes to Neuropathic Pain-Related Conditioned Place Aversion.
Wu XB; He LN; Jiang BC; Wang X; Lu Y; Gao YJ
Neurosci Bull; 2019 Aug; 35(4):613-623. PubMed ID: 31041693
[TBL] [Abstract][Full Text] [Related]
9. CXCL13-mediated recruitment of intrahepatic CXCR5
Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
[TBL] [Abstract][Full Text] [Related]
10. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
[TBL] [Abstract][Full Text] [Related]
11. CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer.
Wang B; Wang M; Ao D; Wei X
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188799. PubMed ID: 36103908
[TBL] [Abstract][Full Text] [Related]
12. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
Yang M; Lu J; Zhang G; Wang Y; He M; Xu Q; Xu C; Liu H
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452206
[TBL] [Abstract][Full Text] [Related]
13. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment.
Ohandjo AQ; Liu Z; Dammer EB; Dill CD; Griffen TL; Carey KM; Hinton DE; Meller R; Lillard JW
Sci Rep; 2019 Oct; 9(1):14963. PubMed ID: 31628349
[TBL] [Abstract][Full Text] [Related]
15. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5.
Jiang BC; Cao DL; Zhang X; Zhang ZJ; He LN; Li CH; Zhang WW; Wu XB; Berta T; Ji RR; Gao YJ
J Clin Invest; 2016 Feb; 126(2):745-61. PubMed ID: 26752644
[TBL] [Abstract][Full Text] [Related]
16. Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer.
Qi XW; Xia SH; Yin Y; Jin LF; Pu Y; Hua D; Wu HR
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1916-24. PubMed ID: 25010623
[TBL] [Abstract][Full Text] [Related]
17. CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma.
Liu JF; Lee CW; Lin CY; Chao CC; Chang TM; Han CK; Huang YL; Fong YC; Tang CH
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847038
[TBL] [Abstract][Full Text] [Related]
18. CXCL13/CXCR5 signaling contributes to diabetes-induced tactile allodynia via activating pERK, pSTAT3, pAKT pathways and pro-inflammatory cytokines production in the spinal cord of male mice.
Liu S; Liu X; Xiong H; Wang W; Liu Y; Yin L; Tu C; Wang H; Xiang X; Xu J; Duan B; Tao A; Zhao Z; Mei Z
Brain Behav Immun; 2019 Aug; 80():711-724. PubMed ID: 31100371
[TBL] [Abstract][Full Text] [Related]
19. Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5.
El-Haibi CP; Sharma P; Singh R; Gupta P; Taub DD; Singh S; Lillard JW
Mol Cancer; 2013 Jun; 12():64. PubMed ID: 23773523
[TBL] [Abstract][Full Text] [Related]
20. The roles of chemokine (C-X-C motif) ligand 13 in spinal cord ischemia-reperfusion injury in rats.
Chen F; Li X; Li Z; Zhou Y; Qiang Z; Ma H
Brain Res; 2020 Jan; 1727():146489. PubMed ID: 31589828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
